Business Context and Reporting Period
Company: The Middleby Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 29, 2002 (Second Quarter of Fiscal 2002)
Business Overview: Middleby operates in two primary segments: the Cooking Systems Group (manufacturing commercial foodservice equipment) and the International Distribution Division. The reporting period includes the full impact of the December 2001 acquisition of Blodgett Holdings, Inc., which significantly expanded the company's product lines and geographic footprint.
Key Financial Metrics
| Metric | Q2 2002 | Q2 2001 | YTD 2002 | YTD 2001 |
|---|---|---|---|---|
| Net Sales | $62.5 million | $25.3 million | $117.0 million | $50.0 million |
| Gross Profit | $21.5 million | $8.2 million | $39.4 million | $16.4 million |
| Gross Margin | 34.4% | 32.6% | 33.7% | 32.8% |
| Operating Income | $8.2 million | $2.2 million | $12.9 million | $4.1 million |
| Net Earnings | $2.8 million | $0.7 million | $3.9 million | $1.2 million |
| Diluted EPS | $0.31 | $0.08 | $0.43 | $0.14 |
| Cash & Equivalents | $0.8 million | $4.6 million | $0.8 million | $4.6 million |
| Total Debt (Current + Long-term) | $83.5 million | $96.2 million | $83.5 million | $96.2 million |
| Operating Cash Flow (YTD) | $10.7 million | ($0.7 million) | $10.7 million | ($0.7 million) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 147% year-over-year in Q2 and 134% YTD, driven primarily by the inclusion of Blodgett operations. Pro-forma comparisons indicate organic growth in core product lines.
- Profitability: Operating income surged due to higher sales volume and improved gross margins (34.4% vs 32.6% in Q2). Management attributes margin expansion to better leverage and cost structure improvements from consolidating Blodgett manufacturing.
- Interest Expense: Interest and deferred financing amortization rose significantly to $3.0 million in Q2 (from $0.2 million in Q2 2001) due to debt incurred for the Blodgett acquisition.
- Restatement: The company restated prior period financials (Q1 2002 and FY 2001) to reclassify stock warrant rights from equity to liabilities under SFAS 133. This resulted in a $2.5 million reduction in shareholders' equity and a $0.3 million gain in Q1 2002 earnings due to fair value adjustments.
- Restructuring: The company completed headcount reductions (153 employees total in H1 2002) and exited two manufacturing facilities in Vermont, reducing facility closure reserves.
Outlook, Risks, and Management Commentary
- Liquidity: Cash and cash equivalents decreased to $0.8 million. However, management cites $22.8 million in available borrowing capacity under the revolving credit facility and expects operating cash flows to meet working capital and debt service needs.
- Debt Structure: Total debt decreased to $83.5 million. The company holds $43.5 million in fixed-rate debt (including subordinated notes with 15.5% interest, 2% paid in kind) and $40.0 million in variable-rate debt. An interest rate swap ($20 million notional) was utilized to fix rates on a portion of variable debt.
- Market Risks:
- Derivative Volatility: Earnings are subject to volatility from the fair value changes of stock warrant rights tied to the acquisition financing.
- Foreign Exchange: The company uses forward contracts to hedge currency exposure but remains exposed to political and economic risks in international markets (e.g., Philippines).
- Integration: Success depends on the continued integration of Blodgett operations and market acceptance of combined product lines.
- Accounting Changes: Adoption of SFAS 142 eliminated goodwill amortization, which previously reduced net income. Future earnings may show higher volatility due to potential impairment charges.
Investor Verification Checklist
- Restatement Impact: Verify the full extent of the SFAS 133 restatement on equity and the ongoing volatility of the warrant liability valuation.
- Debt Service: Confirm the ability to service high-interest subordinated notes (15.5% rate) and the impact of "pay-in-kind" interest on principal growth.
- Cash Position: Monitor the low cash balance ($0.8 million) relative to the $22.8 million credit facility availability and upcoming debt maturities.
- Restructuring Completion: Validate that the $8.0 million remaining reserve for severance and facility closures is sufficient to cover remaining obligations.
- Organic Growth: Distinguish between sales growth driven by the Blodgett acquisition versus organic growth in legacy Middleby product lines.